H 69 (Rivastigmine tartrate 4.5 mg)

Pill imprint H 69 has been identified as Rivastigmine tartrate 4.5 mg.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Rivastigmine tartrate

Imprint:

H 69

Strength:

4.5 mg

Color:

Red

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Cholinesterase inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Aurobindo Pharma Limited

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.